Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Debt (2016 - 2025)

Collegium Pharmaceutical has reported Non-Current Debt over the past 10 years, most recently at $542.1 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $542.1 million for Q4 2025, down 1.57% from a year ago — trailing twelve months through Dec 2025 was $542.1 million (down 1.57% YoY), and the annual figure for FY2025 was $542.1 million, down 1.57%.
  • Non-Current Debt for Q4 2025 was $542.1 million at Collegium Pharmaceutical, up from $505.6 million in the prior quarter.
  • Over the last five years, Non-Current Debt for COLL hit a ceiling of $565.7 million in Q3 2024 and a floor of $61.7 million in Q4 2021.
  • Median Non-Current Debt over the past 5 years was $375.7 million (2022), compared with a mean of $342.7 million.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 544.73% in 2022 and later tumbled 57.13% in 2024.
  • Collegium Pharmaceutical's Non-Current Debt stood at $61.7 million in 2021, then skyrocketed by 544.73% to $397.6 million in 2022, then tumbled by 44.23% to $221.7 million in 2023, then surged by 148.4% to $550.7 million in 2024, then fell by 1.57% to $542.1 million in 2025.
  • The last three reported values for Non-Current Debt were $542.1 million (Q4 2025), $505.6 million (Q3 2025), and $520.6 million (Q2 2025) per Business Quant data.